acebutolol has been researched along with Hearing Loss in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, H; Hayashi, K; Higaki, K; Higashi, T; Ichikawa, A; Ikeda, R; Irie, T; Ishii, A; Ishikawa, Y; Ishitsuka, Y; Kajii, T; Katsuki, H; Kondo, Y; Kurauchi, Y; Matsuo, M; Minami, K; Miwa, T; Motoyama, K; Nakagata, N; Nakashima, M; Namba, N; Okada, Y; Orita, Y; Seki, T; Shirakawa, A; Tachii, K; Takeda, H; Takeo, T; Yamada, Y; Yoshikawa, N | 1 |
1 other study(ies) available for acebutolol and Hearing Loss
| Article | Year |
|---|---|
Fine-tuned cholesterol solubilizer, mono-6-O-α-D-maltosyl-γ-cyclodextrin, ameliorates experimental Niemann-Pick disease type C without hearing loss.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Cholesterol; Excipients; gamma-Cyclodextrins; Hearing Loss; Maltose; Mice; Niemann-Pick Disease, Type C; Ototoxicity; Protons | 2022 |